A Pilot Study Using Weightloss and Exercise to Prevent Recurring Gestational Diabetes in Obese Women
Public ClinicalTrials.gov record NCT00924599. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Prevention of Gestational Diabetes Pilot Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to examine the feasibility of recruiting and providing a behavioral weight loss program prior to pregnancy to reduce gestational diabetes recurrence.
Study identification
- NCT ID
- NCT00924599
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 12 participants
Conditions and interventions
Conditions
Interventions
- Prevention of recurrent gestational diabetes through weight loss and exercise (English & Spanish) Behavioral
- Lifestyle education (English & Spanish) Behavioral
Behavioral
Eligibility (public fields only)
- Age range
- 18 Years to 40 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2009
- Primary completion
- May 31, 2014
- Completion
- May 31, 2014
- Last update posted
- Jul 25, 2016
2009 – 2014
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sierra Vista Regional Medical Center | San Luis Obispo | California | 93405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Gestational Diabetes trials
Other public records listing Gestational Diabetes. Sorted by last update posted; newest first. Not a recommendation.
- NCT07174245: Pregnancy and Postpartum CGM in GDM Recruiting
- NCT06457139: Preventing T2DM After GDM With Immediate Postpartum Screening Recruiting
- NCT05124808: Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes Recruiting
- NCT06571487: Growth Hormone Resistance of Beta-cells A Recruiting
- NCT07565727: Cardiometabolic Disease and Substrate Metabolism Recruiting
- NCT05482789: Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00924599, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 25, 2016 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00924599 live on ClinicalTrials.gov.